Literature DB >> 5018870

Muscular syndrome after clofibrate.

N Katsilambros, J Braaten, B D Ferguson, R F Bradley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5018870     DOI： 10.1056/nejm197205182862014

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid.

Authors:  E C Aromataris; D S Astill; G Y Rychkov; S H Bryant; A H Bretag; M L Roberts
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Clofibrate-induced myopathy in the rat.

Authors:  H Teräväinen; A Larsen; M Hillbom
Journal:  Acta Neuropathol       Date:  1977-08-16       Impact factor: 17.088

Review 3.  Bezafibrate induced rhabdomyolysis.

Authors:  E Kanterewicz; R Sanmartí; J Riba; I Trias; J Autonell; J Brugués
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

4.  Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.

Authors:  A Bardosi; P Scheidt; H H Goebel
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  Clofibrate-induced myotonia in the rat.

Authors:  A Eberstein; J Goodgold; R Johnston
Journal:  Experientia       Date:  1978-12-15

6.  [Fat and renal failure--therapeutic aspects].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-08

7.  Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 8.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

9.  Clinical pharmacokinetics of bezafibrate in patients with impaired renal function.

Authors:  P Anderson; H E Norbeck
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

Authors:  S Levak-Frank; H Radner; A Walsh; R Stollberger; G Knipping; G Hoefler; W Sattler; P H Weinstock; J L Breslow; R Zechner
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.